Wigzell Hans Lennart Rudolf 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 8, 2022
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-07+5,077→ 5,077 totalExercise: $80.42From: 2023-03-07Exp: 2032-03-07→ Common Stock (5,077 underlying) - Award
Common Stock
2022-03-07+2,953→ 19,471 total
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023.